Share-based Payment Arrangements (Tables)

3 Months Ended

Mar. 26, 2022

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Thirteen Weeks Ended
	March 26, 2022			March 27, 2021
Total cost of the Plans during the period	$	1,995		$	4,029
Amount of related income tax benefit recognized during the period		(3,360	)		(1,341	)
Net cost of the Plans during the period	$	(1,365	)	$	2,688

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

	Number of RSUs			Weighted Average Grant Date Fair Value
Outstanding at December 25, 2021		209,399		$	102.90
Granted		49,405		$	139.78
Shares earned in excess of target (1)		91,497		$	92.58
Vested shares, including shares earned in excess of target		(174,366	)	$	96.14
Forfeited		(15,044	)	$	103.31
Outstanding at March 26, 2022		160,891		$	115.64

(1) Represents additional shares earned under each of the February 2, 2017; February 2, 2018 and February 1, 2019 RSU awards as fiscal year 2021 financial results exceeded target performance level.

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 25, 2021		56,436		$	125.16
Granted		17,008		$	152.44
Vested		(21,500	)	$	110.16
Forfeited		(2,302	)	$	108.59
Non-vested at March 26, 2022		49,642		$	141.77

Summary of Information Regarding Stock Options

The following table summarizes information regarding the Company’s outstanding stock options under the Plans:

	Number of Options			Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (000s)
Options outstanding at December 25, 2021		8,570		$	55.42
Exercised		(3,500	)	$	54.01
Options outstanding at March 26, 2022		5,070		$	56.40		0.8	$	495
Options exercisable at March 26, 2022		5,070		$	56.40		0.8	$	495